Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis Allen, P., Chen, Q. C., Lu, X., O'Shea, K., Chmiel, J., Sukhanova, M., Slonim, L., Savas, H., Mou, E., Pro, B., Evens, A. M., Palmer, B., Advani, R., Gordon, L. I., Winter, J. N. AMER SOC HEMATOLOGY. 2021

View details for DOI 10.1182/blood-2021-147042

View details for Web of Science ID 000736398801008